Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein geranylgeranyltransferase type I subunit beta pseudogene 1 (PGGT1BP1) is a non-coding pseudogene related to the protein geranylgeranyltransferase type I beta subunit. Unlike the canonical enzyme subunit (PGGT1B), PGGT1BP1 does not encode a functional protein and has no established role in cellular biology, human disease, or therapeutic targeting. It is annotated as a pseudogene, meaning it represents a non-functional genomic locus typically lacking protein expression or regulatory function. No drugs or clinical uses are associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein geranylgeranyltransferase type I subunit beta pseudogene 1 (PGGT1BP1).